To investigate the cascading effects of GSK470-mediated targeting of PDPK1 in RCC, we performed immunoblotting to measure the expression of PDPK1, Akt, mTOR, and downstream members of this pathway. This evidence concerns the gene AKT1 and renal cell carcinoma.